1 This insulin secretion causes an overall decrease in blood sugar levels, reduces the production of glucagon, which prevents the release of glucose storage from the liver, and induces a satiety response that elevates insulin sensitivity and causes weight loss
Rehfeld 2021)
Bao Z, Kim J, Kwok C, Le Devedec F, Allen C
While it is authorized, supply levels can vary, and it is subject to the same strict residency and prescription rules as other GLP-1 medications
3 Future studies are needed to determine whether this class of medications inhibits progression from nonexudative to neovascular or late atrophic stages of AMD
This partial reversal may be driven by factors such as compliance challenges, waning drug efficacy or measurement limitations